Skip to main content
. 2018 Jul 17;5:89. doi: 10.3389/fcvm.2018.00089

Figure 1.

Figure 1

Multi-omics approach for precision medicine. Multi-omics (i.e., genome, epigenome, transcriptome, proteome, metabolome, microbiome, and envirome) data are collected from patients and integrated to create their individual molecular signatures (i.e., complex biomarkers), which are then used to select an appropriate drug for a particular patient, thus improving the treatment efficiency and reducing the possible side effects.